β-Amyloid (4-10)

These antibodies targeting the beta-amyloid (4-10) epitope effectively inhibit cytotoxicity, reduce amyloid plaque formation, and alleviate spatial memory deficits in murine Alzheimer's disease models without inducing an inflammatory response. They are valuable tools for in vivo and in vitro research into neuroprotective mechanisms and therapeutic strategies.